Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, multiple myeloma, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• AVN-944

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Acute Leukemia, Chronic Leukemia | Phase 1 | Status: COMPLETED